tiprankstipranks
Trending News
More News >
Xbrane Biopharma AB (SE:XBRANE)
:XBRANE
Sweden Market

Xbrane Biopharma AB (XBRANE) Cash flow

Compare
9 Followers

Xbrane Biopharma AB Cash Flow

SE:XBRANE's free cash flow for Q3 2025 was kr-49.44M. For the 2025 fiscal year, SE:XBRANE's free cash flow was decreased by kr237.47M and operating cash flow was kr-49.44M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
kr -133.73Mkr -406.68Mkr -193.92Mkr -219.61Mkr -238.41M
Investing Cash Flow
kr -52.25Mkr -16.77Mkr -60.13Mkr -77.35Mkr -3.85M
Financing Cash Flow
kr 243.62Mkr 298.70Mkr 148.86Mkr 349.37Mkr 322.72M
End Cash Position
kr 124.33Mkr 65.40Mkr 193.99Mkr 295.18Mkr 243.14M
Free Cash Flow
kr -185.97Mkr -423.45Mkr -254.04Mkr -296.96Mkr -242.26M
Currency in SEK

Xbrane Biopharma AB Cash Flow